A.Vogel A.Vogel
A.Vogel
A.Vogel A.VogelPlant Profile
A.VogelLinks
A.VogelLatest News
A.VogelNewsletter
A.Vogel

View from Alfred Vogel's clinic at Teufen

A.Vogel
A.Vogel
A.Vogel

Echinacea - The Latest Research

«The Lancet Infectious Diseases» has published research concluding that Echinacea can more than half the risk of catching a common cold. This is the conclusion drawn by researchers from the School of Pharmacy at the University of Connecticut, who looked at 14 different studies on Echinacea.

Overall, Echinacea was shown to decrease the odds of developing a cold by 58% and reduce the duration of colds by a day-and-a-half in people who were infected.

Echinacea reduced the likelihood of participants catching a cold naturally (i.e. in normal circumstances such as working with someone who has a cold) by 65%,  and Professor Ron Cutler of the University of East London said that Echinacea, “decreases the severity of cough, headache and nasal congestion,” if people have already caught a cold. He gave it as his opinion that, “people with impaired immune function might benefit from taking Echinacea during the winter months to prevent colds and flu.”

Most of the positive trials on Echinacea published in the last few years have used an ethanolic extract (tincture) of Echinacea purpurea produced from freshly harvested plant material – the same specifications as Echinaforce, which has had a medicine’s licence proving its safety and efficacy for colds, flu and upper respiratory tract infections for more than 10 years.

All Echinaceas are not the same:
make sure you use the best!

A.Vogel A.Vogel A.Vogel
Alfred Vogel – the name is our promise
The philosophy of our company's founder